Nant Health, Inc. NH
We take great care to ensure that the data presented and summarized in this overview for NantHealth, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in NH
Top Purchases
Top Sells
About NH
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
Insider Transactions at NH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 28
2023
|
Patrick Soon Shiong Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
15,921,888
+26.63%
|
$143,296,992
$9.5 P/Share
|
Sep 13
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,200
-3.91%
|
$9,200
$1.96 P/Share
|
Sep 13
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,200
+3.77%
|
$0
$0.55 P/Share
|
Sep 10
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,320
-3.14%
|
$14,640
$2.05 P/Share
|
Sep 10
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,320
+3.04%
|
$0
$0.55 P/Share
|
Sep 08
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,700
-2.04%
|
$9,400
$2.25 P/Share
|
Sep 08
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,700
+2.0%
|
$0
$0.55 P/Share
|
Sep 07
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,613
-6.85%
|
$33,226
$2.3 P/Share
|
Sep 07
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,613
+6.41%
|
$0
$0.55 P/Share
|
Sep 03
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,505
-0.66%
|
$3,010
$2.34 P/Share
|
Sep 03
2021
|
Ronald Allen Louks Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,505
+0.66%
|
$0
$0.55 P/Share
|
Apr 13
2021
|
Patrick Soon Shiong Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
1,689,189
+50.0%
|
$3,378,378
$2.96 P/Share
|
Mar 12
2021
|
Ronald Allen Louks Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
80,000
-26.16%
|
$240,000
$3.71 P/Share
|